Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Prostate Cancer

Free Subscription Articles published in Clin Imaging Retrieve available abstracts of 11 articles: HTML format

Single Articles

September 2025
1. SIMON BD, Harmon SA, Turkbey B
   Reply to "A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer".
   Clin Imaging. 2025 Sep 13:110616. doi: 10.1016/j.clinimag.2025.110616.
   PubMed    
   
   
   
2. DEFFLER C, Sedeh AE, Leitman E, Ng TSC, et al
   The role of PSMA PET/CT in identifying benign and malignant intracranial lesions in patients with prostate cancer.
   Clin Imaging. 2025 Sep 12:110620. doi: 10.1016/j.clinimag.2025.110620.
   PubMed     Abstract available
   
   
   
3. APHALE P, Dokania S, Shekhar H
   A critical appraisal and methodological inquiry into an automated multimodal deep learning model for predicting biochemical recurrence in prostate cancer.
   Clin Imaging. 2025 Sep 11:110615. doi: 10.1016/j.clinimag.2025.110615.
   PubMed    
   
   
   
4. CHIMMULA RR, Green M, Tann M, Koch M, et al
   Comparative analysis of machine learning-derived nomogram and biomarkers in predicting side-specific extraprostatic extension: Preliminary findings.
   Clin Imaging. 2025;125:110556.
   PubMed     Abstract available
   
   
   August 2025
5. SIMON BD, Harmon SA, Merriman KM, Tetreault J, et al
   A multimodal automated deep learning-based model for predicting biochemical recurrence of prostate cancer following prostatectomy from baseline MRI, Presurgical clinical covariates.
   Clin Imaging. 2025;126:110579.
   PubMed     Abstract available
   
   
   July 2025
6. SHAH N, Sedeh AE, Deffler C, Ng TSC, et al
   The role of PSMA PET/CT in distinguishing malignant from benign solitary bone lesions in prostate cancer patients.
   Clin Imaging. 2025;125:110570.
   PubMed     Abstract available
   
   
   June 2025
7. NAKROUR N, Cochran RL, Mercaldo ND, Bradley W, et al
   Impact of artificial intelligence assisted lesion detection on radiologists' interpretation at multiparametric prostate MRI.
   Clin Imaging. 2025;122:110484.
   PubMed     Abstract available
   
   
   April 2025
8. FENNER J, Samim M, Raad RA, Shankar DS, et al
   CT-guided biopsy of 18F-piflufolastat radiotracer avid lesions in osseous metastatic prostate disease: Initial experience, technical factors and biopsy yield.
   Clin Imaging. 2025;120:110437.
   PubMed     Abstract available
   
   
   January 2025
9. ESENGUR OT, Yilmaz EC, Ozyoruk KB, Chen A, et al
   Multimodal approach to optimize biopsy decision-making for PI-RADS 3 lesions on multiparametric MRI.
   Clin Imaging. 2025;117:110363.
   PubMed     Abstract available
   
   
   
10. COCHRAN RL, Milshteyn E, Ghosh S, Nakrour N, et al
    Minimizing prostate diffusion weighted MRI examination time through deep learning reconstruction.
    Clin Imaging. 2025;117:110341.
    PubMed     Abstract available
    
    
    December 2024
11. BLYTHE JA, Ng TSC
    Ethical principles for practice building in the era of targeted radioligand therapy.
    Clin Imaging. 2024;116:110334.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.